The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Advisory Committee on Non-prescription Medicines (ACNM)
Role of the ACNM
The Advisory Committee on Non-prescription Medicines (ACNM) was formed in January 2010. The ACNM advise and make recommendations to the TGA regarding the entry of non-prescription medicines on the Australian Register of Therapeutic Goods (the Register). This includes:
- inclusion of a non-prescription medicine on the Register
- changes to an entry of a non-prescription medicine on the Register
- removal or retention of a non-prescription medicine on the Register.
ACNM may also provide advice to the TGA on other matters concerning a non-prescription medicine, and any other matters referred to it by the TGA.
The ACNM supersedes the Medicines Evaluation Committee (MEC).
In 2017, ACNM was replaced by the Advisory Committee on Medicines (ACM).